Source link : https://www.newshealth.biz/health-news/enthusiasm-for-transplant-free-strategies-for-low-risk-relapsed-hodgkin-lymphoma/
Non-transplant salvage therapy for low-risk relapsed/refractory pediatric classical Hodgkin lymphoma (cHL) had high rates of progression-free (PFS) and overall survival (OS) at 3-5 years, three separate studies showed. A multicenter European study resulted in a 5-year PFS of 89.7% and OS of 97.4% with PET-guided chemotherapy and radiotherapy for low-risk relapsed disease. Results were nearly […]
Author : News Health
Publish date : 2025-01-02 22:20:36
Copyright for syndicated content belongs to the linked Source.